Apelin-13 Induces Autophagy in Hepatoma Hepg2 Cells Through Erk1/2 Signaling Pathway-Dependent Upregulation of Beclin1

Qiulin Huang,Xuan Liu,Chao Cao,Junyue Lei,Dong Han,Guodong Chen,Jia Yu,Linxi Chen,Deguan Lv,Zhongyu Li
DOI: https://doi.org/10.3892/ol.2015.3991
2016-01-01
Oncology Letters
Abstract:The aim of the present study was to investigate the effect of Apelin-13 on autophagy in hepatocellular carcinoma HepG2 cells and the underlying mechanism of the effect. The HepG2 cells were treated with Apelin-13 at a final concentration of 0.0001, 0.001, 0.01 and 0.1 mu mol/l for 24 h. Cells were also treated with 10 mu mol/l PD98059 for 24 h. The expression of the extracellular signal-regulated kinase (ERK) 1/2, phosphorylated ERK1/2 (pERK1/2) and Beclin1 proteins were detected by western blot analysis. Beclin1 mRNA expression was also detected by reverse transcription-polymerase chain reaction. Autophagy was observed using fluorescence microscopy subsequent to monodansylcadaverine (MDC) staining. Following treatment with the various concentrations of Apelin-13, the expression of the ERK1/2 protein remained at a similar level, whereas the expression of pERK1/2 increased in a dosedepen-dent manner. Compared with the control group, the increase was significant (P< 0.05). Similarly, Beclin1 expression was upregulated at the protein and mRNA levels by Apelin13 treat-ment in a dose-dependent manner and was significantly increased compared with the control group. However, following treatment with the Apelin-13 inhibitor PD98059, the expression of pERK1/2, Beclin1 protein and Beclin1 mRNA were significantly decreased (P< 0.05). In addition, Apelin-13 induced the autophagy of HepG2 cells in a dose-dependent manner, as revealed by MDC staining. PD98059 inhibited autophagy of HepG2 cells induced by Apelin-13. Therefore, Apelin-13 may promote autophagy in HepG2 cells by inducing the phosphorylation of ERK1/2 and upregulating the expression of Beclin1.
What problem does this paper attempt to address?